Phentermine Hydrochloride

Product NDC: 0527-1445
11-digit product format: 005271445
Labeler code: 0527
Product ID: 0527-1445_71a5941a-3831-4042-989d-1c47e1b65bab
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Phentermine Hydrochloride
Dosage form: TABLET
Route: ORAL
Labeler: Lannett Company, Inc.
Application: ANDA040555
Marketing category: ANDA
Marketing start: 2005-04-15
Marketing end: 0000-00-00
Substance: PHENTERMINE HYDROCHLORIDE
Active strength: 38 mg/1
Pharmacologic classes: Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]
DEA schedule: CIV
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0527-1445		D	Discontinued by firm	2026-08-07
excluded package	package	0527-1445	0527-1445-01	D	Discontinued by firm	2026-08-07
excluded package	package	0527-1445	0527-1445-10	D	Discontinued by firm	2026-08-07
excluded package	package	0527-1445	0527-1445-30	D	Discontinued by firm	2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0527-1445-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0527-1445-30	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0527-1445-10	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0527-1445-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0527-1445-30	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0527-1445-10	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0527-1445-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0527-1445-30	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0527-1445-10	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0527-1445-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0527-1445-30	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0527-1445-10	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0527-1445-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0527-1445-30	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0527-1445-10	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0527-1445-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0527-1445-30	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0527-1445-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0527-1445-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0527-1445-30	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0527-1445-10	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0527-1445-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0527-1445-30	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0527-1445-10	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0527-1445-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0527-1445-30	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0527-1445-10	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A040555-001	PHENTERMINE HYDROCHLORIDE	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL			2005-04-15

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL		2005-04-15	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A040555-001	PHENTERMINE HYDROCHLORIDE	37.5MG	TABLET / ORAL	AA	2005-04-15	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040555-001	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040555-001	AA	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040555-001	AA	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040555-001	AA	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A040555-001	AA	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A040555-001	AA	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A040555-001	AA	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A040555-001	AA	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A040555-001	AA	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A040555-001	AA	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A040555-001	AA	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A040555-001	AA	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A040555-001	AA	1	`ea99ee380514…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A040555-001	AA	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
3d272a3f-17c0-421d-bc43-3cbdb719258d	Product name	1	20250303
32c2b0bd-1f13-4890-99e0-dcd2ea16e1ab	Product name	2	20230717
ebeae3eb-385d-62da-8827-5ffa80b14e90	Product name	2	20170810
1d682039-1122-1cb7-f3f4-c0a028b98748	Product name	4	20170124
8ef9ca65-1a6c-7225-351d-36066d0f8e56	Product name	3	20161229

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
0527-1445-01	2024-01-30	C162847	48780-1	1030e365-3d7f-111a-e063-dadaa90a10e2	These highlights do not include all the information needed to use PHENTERMINE HYDROCHLORIDE TABLETS, USP safely and effectively. See full prescribing information for PHENTERMINE HYDROCHLORIDE TABLETS, USP. PHENTERMINE HYDROCHLORIDE tablets, USP for oral use CIV Initial U.S. Approval: 1959
0527-1445-10	2024-01-30	C162847	48780-1	1030e365-3d7f-111a-e063-dadaa90a10e2	These highlights do not include all the information needed to use PHENTERMINE HYDROCHLORIDE TABLETS, USP safely and effectively. See full prescribing information for PHENTERMINE HYDROCHLORIDE TABLETS, USP. PHENTERMINE HYDROCHLORIDE tablets, USP for oral use CIV Initial U.S. Approval: 1959
0527-1445-30	2024-01-30	C162847	48780-1	1030e365-3d7f-111a-e063-dadaa90a10e2	These highlights do not include all the information needed to use PHENTERMINE HYDROCHLORIDE TABLETS, USP safely and effectively. See full prescribing information for PHENTERMINE HYDROCHLORIDE TABLETS, USP. PHENTERMINE HYDROCHLORIDE tablets, USP for oral use CIV Initial U.S. Approval: 1959

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0527-1445-01	EA - Each	0527-1445	3eec4ee5-af6d-4384-872f-5e45dcc835e0	1	2012-07-24
0527-1445-10	EA - Each	0527-1445	618434e9-d736-40c6-a9e4-91aeab056a45	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
PHENTERMINE HYDROCHLORIDE	ACTIVE INGREDIENT	0K2I505OTV	PHENTERMINE HYDROCHLORIDE TABLET [LANNETT COMPANY, INC.]	14
PHENTERMINE	ACTIVE MOIETY	C045TQL4WP	PHENTERMINE HYDROCHLORIDE TABLET [LANNETT COMPANY, INC.]	14
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	PHENTERMINE HYDROCHLORIDE TABLET [LANNETT COMPANY, INC.]	14
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	PHENTERMINE HYDROCHLORIDE TABLET [LANNETT COMPANY, INC.]	14
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PHENTERMINE HYDROCHLORIDE TABLET [LANNETT COMPANY, INC.]	14
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	PHENTERMINE HYDROCHLORIDE TABLET [LANNETT COMPANY, INC.]	14
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PHENTERMINE HYDROCHLORIDE TABLET [LANNETT COMPANY, INC.]	14
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	PHENTERMINE HYDROCHLORIDE TABLET [LANNETT COMPANY, INC.]	14
SUCROSE	INACTIVE INGREDIENT	C151H8M554	PHENTERMINE HYDROCHLORIDE TABLET [LANNETT COMPANY, INC.]	14
PHENTERMINE HYDROCHLORIDE	ACTIVE INGREDIENT	0K2I505OTV	PHENTERMINE HYDROCHLORIDE TABLET [UNIT DOSE SERVICES]	3
PHENTERMINE	ACTIVE MOIETY	C045TQL4WP	PHENTERMINE HYDROCHLORIDE TABLET [UNIT DOSE SERVICES]	3
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	PHENTERMINE HYDROCHLORIDE TABLET [UNIT DOSE SERVICES]	3
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	PHENTERMINE HYDROCHLORIDE TABLET [UNIT DOSE SERVICES]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PHENTERMINE HYDROCHLORIDE TABLET [UNIT DOSE SERVICES]	3
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	PHENTERMINE HYDROCHLORIDE TABLET [UNIT DOSE SERVICES]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PHENTERMINE HYDROCHLORIDE TABLET [UNIT DOSE SERVICES]	3
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	PHENTERMINE HYDROCHLORIDE TABLET [UNIT DOSE SERVICES]	3
SUCROSE	INACTIVE INGREDIENT	C151H8M554	PHENTERMINE HYDROCHLORIDE TABLET [UNIT DOSE SERVICES]	3
PHENTERMINE HYDROCHLORIDE	ACTIVE INGREDIENT	0K2I505OTV	PHENTERMINE HYDROCHLORIDE TABLET [PROFICIENT RX LP]	1
PHENTERMINE HYDROCHLORIDE	ACTIVE INGREDIENT	0K2I505OTV	PHENTERMINE HYDROCHLORIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
PHENTERMINE HYDROCHLORIDE	ACTIVE INGREDIENT	0K2I505OTV	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1
PHENTERMINE HYDROCHLORIDE	ACTIVE INGREDIENT	0K2I505OTV	PHENTERMINE HYDROCHLORIDE TABLET [NORTHWIND PHARMACEUTICALS]	1
PHENTERMINE	ACTIVE MOIETY	C045TQL4WP	PHENTERMINE HYDROCHLORIDE TABLET [PROFICIENT RX LP]	1
PHENTERMINE	ACTIVE MOIETY	C045TQL4WP	PHENTERMINE HYDROCHLORIDE TABLET [NORTHWIND PHARMACEUTICALS]	1
PHENTERMINE	ACTIVE MOIETY	C045TQL4WP	PHENTERMINE HYDROCHLORIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
PHENTERMINE	ACTIVE MOIETY	C045TQL4WP	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	PHENTERMINE HYDROCHLORIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	PHENTERMINE HYDROCHLORIDE TABLET [PROFICIENT RX LP]	1
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	PHENTERMINE HYDROCHLORIDE TABLET [PROFICIENT RX LP]	1
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	PHENTERMINE HYDROCHLORIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PHENTERMINE HYDROCHLORIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PHENTERMINE HYDROCHLORIDE TABLET [PROFICIENT RX LP]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	PHENTERMINE HYDROCHLORIDE TABLET [PROFICIENT RX LP]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	PHENTERMINE HYDROCHLORIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PHENTERMINE HYDROCHLORIDE TABLET [PROFICIENT RX LP]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PHENTERMINE HYDROCHLORIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	PHENTERMINE HYDROCHLORIDE TABLET [PROFICIENT RX LP]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	PHENTERMINE HYDROCHLORIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	PHENTERMINE HYDROCHLORIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	PHENTERMINE HYDROCHLORIDE TABLET [PROFICIENT RX LP]	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	PHENTERMINE HYDROCHLORIDE TABLET [DIRECT RX]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
0K2I505OTV	PHENTERMINE HYDROCHLORIDE	1197-21-3	PHENTERMINE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
803353	phentermine HCl 37.5 MG Oral Tablet	PSN	ef061dd2-1b35-49bf-beda-8c9fe02e5f9f	10
803353	phentermine hydrochloride 37.5 MG Oral Tablet	SCD	ef061dd2-1b35-49bf-beda-8c9fe02e5f9f	10
803353	phentermine hydrochloride 37.5 MG (equivalent to phentermine 30 MG) Oral Tablet	SY	ef061dd2-1b35-49bf-beda-8c9fe02e5f9f	10
803353	phentermine HCl 37.5 MG Oral Tablet	PSN	501437ae-f4a2-4e54-b033-eccc53a06037	8
803353	phentermine hydrochloride 37.5 MG Oral Tablet	SCD	501437ae-f4a2-4e54-b033-eccc53a06037	8
803353	phentermine hydrochloride 37.5 MG (equivalent to phentermine 30 MG) Oral Tablet	SY	501437ae-f4a2-4e54-b033-eccc53a06037	8
900038	phentermine HCl 30 MG Oral Capsule	PSN	8a947cf6-c578-0405-e053-2995a90a3e0e	6
803353	phentermine HCl 37.5 MG Oral Tablet	PSN	8a947cf6-c578-0405-e053-2995a90a3e0e	6
900038	phentermine hydrochloride 30 MG Oral Capsule	SCD	8a947cf6-c578-0405-e053-2995a90a3e0e	6
803353	phentermine hydrochloride 37.5 MG Oral Tablet	SCD	8a947cf6-c578-0405-e053-2995a90a3e0e	6
900038	phentermine hydrochloride 30 MG (equivalent to phentermine 24 MG) Oral Capsule	SY	8a947cf6-c578-0405-e053-2995a90a3e0e	6
803353	phentermine hydrochloride 37.5 MG (equivalent to phentermine 30 MG) Oral Tablet	SY	8a947cf6-c578-0405-e053-2995a90a3e0e	6
803353	phentermine HCl 37.5 MG Oral Tablet	PSN	d0663bfb-810c-44f9-acc1-3166fe6eedde	2
803353	phentermine hydrochloride 37.5 MG Oral Tablet	SCD	d0663bfb-810c-44f9-acc1-3166fe6eedde	2
803353	phentermine hydrochloride 37.5 MG (equivalent to phentermine 30 MG) Oral Tablet	SY	d0663bfb-810c-44f9-acc1-3166fe6eedde	2
803353	phentermine HCl 37.5 MG Oral Tablet	PSN	8739f879-9af6-4fd6-b8b0-12dc4fee20a0	1
803353	phentermine hydrochloride 37.5 MG Oral Tablet	SCD	8739f879-9af6-4fd6-b8b0-12dc4fee20a0	1
803353	phentermine hydrochloride 37.5 MG (equivalent to phentermine 30 MG) Oral Tablet	SY	8739f879-9af6-4fd6-b8b0-12dc4fee20a0	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0527-1445-01	00527144501	100 TABLET in 1 BOTTLE (0527-1445-01)	100 tablet	2005-04-15	0000-00-00	No	No	Current
0527-1445-10	00527144510	1000 TABLET in 1 BOTTLE (0527-1445-10)	1000 tablet	2005-04-15	0000-00-00	No	No	Current
0527-1445-30	00527144530	30 TABLET in 1 BOTTLE (0527-1445-30)	30 tablet	2005-04-15	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
PHENTERMINE HCL C-IV	Direct_Rx	2023-04-12	HUMAN PRESCRIPTION DRUG LABEL	6
Phentermine HCL 37.5mg Tablets	Advanced Rx Pharmacy of Tennessee, LLC	2022-11-10	HUMAN PRESCRIPTION DRUG LABEL	5
Phentermine Hydrochloride	Asclemed USA, Inc. \| ASCLEMED USA INC. DBA ENOVACHEM	2022-10-12	HUMAN PRESCRIPTION DRUG LABEL	2
Phentermine Hydrochloride	Preferred Pharmaceuticals, Inc.	2021-08-30	HUMAN PRESCRIPTION DRUG LABEL	7
Phentermine Hydrochloride	Unit Dose Services	2021-08-05	HUMAN PRESCRIPTION DRUG LABEL	10
Phentermine Hydrochloride	RPK Pharmaceuticals, Inc.	2020-12-16	HUMAN PRESCRIPTION DRUG LABEL	3
Phentermine Hydrochloride	Lannett Company, Inc.	2020-11-17	HUMAN PRESCRIPTION DRUG LABEL	23
Phentermine Hydrochloride	Proficient Rx LP	2020-04-01	HUMAN PRESCRIPTION DRUG LABEL	4
PHENTERMINE HYDROCHLORIDE	DIRECT RX	2020-01-21	HUMAN PRESCRIPTION DRUG LABEL	8
Phentermine Hydrochloride	CALVIN, SCOTT AND COMPANY, INCORPORATED	2019-11-19	HUMAN PRESCRIPTION DRUG LABEL	2
Phentermine Hydrochloride	Aidarex Pharmaceuticals LLC	2017-02-28	HUMAN PRESCRIPTION DRUG LABEL	1
Phentermine hydrochloride - Northwind Pharmaceuticals \| EPM Packaging	Northwind Pharmaceuticals \| EPM Packaging	2014-06-19	HUMAN PRESCRIPTION DRUG LABEL	1